VG LIFE SCIENCES INC.

Highlights VG Life Sciences Inc.

Equities

VGLS

US91822T1016

Market Closed - OTC Markets Other stock markets 15:53:06 2024-05-17 EDT			5-day change	1st Jan Change
0.0001 ^USD	0.00%		0.00%	+9,900.00%

2018	Feelux Co., Ltd completed the acquisition of 23.09% stake in VG Life Sciences Inc. from Alpha Holdings, Inc. and others for KRW 17.3 billion.	CI
2017	Alpha Holdings, Inc. cancelled an additional stake of 12.49% in VG Life Sciences Inc from TJU Asset Management, LLC and Penn Life Science, LLC.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Feelux Co., Ltd completed the acquisition of 23.09% stake in VG Life Sciences Inc. from Alpha Holdings, Inc. and others for KRW 17.3 billion.	18-11-22	CI
Alpha Holdings, Inc. cancelled an additional stake of 12.49% in VG Life Sciences Inc from TJU Asset Management, LLC and Penn Life Science, LLC.	17-10-11	CI
Alpha Holdings, Inc. agreed to acquire an additional stake of 12.49% in VG Life Sciences Inc from TJU Asset Management, LLC and Penn Life Science, LLC for KRW 4.7 billion.	16-10-11	CI
VG Life Sciences Inc. Progress Update Phase I Cancer Study	14-09-04	CI
VG Life Sciences Inc. Reports Clinical Outcomes in Phase I Cancer Study	14-03-14	CI
VG Life Sciences, Inc. Announces Update on Phase I Cancer Study	13-12-13	CI
VG Life Sciences Inc. Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial	13-04-04	CI
VG Life Sciences Inc. Completes First Stage of its Phase I Trial to Treat Ovarian Cancer	13-01-31	CI
VG Life Sciences Inc. Expands Ovarian Cancer Trial	13-01-14	CI
Viral Genetics Inc. Submits Pre-IND Document for Lyme Disease Drug Candidate to United States Food and Drug Administration	12-03-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW